Anti-CD16/CD80 antibody (Clone: 3G8) {PerCP/Cyanine5.5}

Referência NB-22-62781-100

Tamanho : 100Tests

Marca : Neo Biotech

Contactar o distribuidor local :


Telefone : +1 850 650 7790

General Info

Host: Mouse
Applications: FC
Reactivity: Human
Note: FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-T-lymphocyte activation antigen CD80 is suitable for use in Flow Cytometry research applications.
Clonality: Monoclonal
Clone ID: 3G8
Conjugation: PerCP/Cyanine5.5
Isotype: IgG1k
Formulation: PBS with 0.05% Proclin300, 1% BSA
Storage Instruction: Recommend storing between 2-8°C and protecting from prolonged exposure to light. Do not freeze this product.

Information

Gene Symbol: CD80
Gene ID: 941
Uniprot ID: CD80_HUMAN

Description

Tissue Specificity Expressed on activated B-cells, macrophages and dendritic cells.
Function Involved in the costimulatory signal essential for T-lymphocyte activation. T-cell proliferation and cytokine production is induced by the binding of CD28, binding to CTLA-4 has opposite effects and inhibits T-cell activation. (Microbial infection) Acts as a receptor for adenovirus subgroup B.
Protein Name T-Lymphocyte Activation Antigen Cd80
Activation B7-1 Antigen
Bb1
Ctla-4 Counter-Receptor B7.1
B7
Cd Antigen Cd80
Database Links Reactome: R-HSA-1257604
Reactome: R-HSA-2219530
Reactome: R-HSA-389356
Reactome: R-HSA-389357
Reactome: R-HSA-389359
Reactome: R-HSA-389513
Reactome: R-HSA-6783783
Reactome: R-HSA-6811558
Cellular Localisation Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Names Anti-T-Lymphocyte Activation Antigen Cd80 antibody
Anti-Activation B7-1 Antigen antibody
Anti-Bb1 antibody
Anti-Ctla-4 Counter-Receptor B7.1 antibody
Anti-B7 antibody
Anti-Cd Antigen Cd80 antibody
Anti-CD80 antibody
Anti-CD28LG antibody
Anti-CD28LG1 antibody
Anti-LAB7 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance